Response to novel drugs before and after allogeneic stem cell transplantation in patients with relapsed multiple myeloma
Keywords:
Multiple myeloma
Allogeneic hematopoietic stem
Cell transplantation
Allo-HSCT
Proteasome inhibitor
Immunomodulatory drug
Note:
Under a Creative Commons license
Citation:
Lopez-Corral, L. (Lucia); Caballero-Velázquez, T. (Teresa); Lopez-Godino, O. (Oriana); et al. "Response to novel drugs before and after allogeneic stem cell transplantation in patients with relapsed multiple myeloma". Biology of Blood and Marrow Transplantation. 25 (9), 2019, 1703 - 1712
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.